...
首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >Antisense oligonucleotides targeting protein kinase C-alpha, -beta I, or -delta but not -eta inhibit lipopolysaccharide-induced nitric oxide synthase expression in RAW 264.7 macrophages: involvement of a nuclear factor kappa B-dependent mechanism.
【24h】

Antisense oligonucleotides targeting protein kinase C-alpha, -beta I, or -delta but not -eta inhibit lipopolysaccharide-induced nitric oxide synthase expression in RAW 264.7 macrophages: involvement of a nuclear factor kappa B-dependent mechanism.

机译:靶向蛋白激酶C-α,-βI或-δ但不-β的反义寡核苷酸可抑制RAW 264.7巨噬细胞中脂多糖诱导的一氧化氮合酶表达:涉及核因子κB依赖性机制。

获取原文
获取原文并翻译 | 示例

摘要

The signaling pathway for protein kinase C (PKC) activation and the role of PKC isoforms in LPS-induced nitric oxide (NO) release were studied in RAW 264.7 macrophages. The tyrosine kinase inhibitor genestein attenuated LPS-induced NO release and inducible nitric oxide synthase (iNOS) expression, as did the phosphoinositide-specific phospholipase C (PI-PLC) inhibitor U73122 and the phosphatidylcholine-specific phospholipase C (PC-PLC) inhibitor D609. LPS stimulated phosphatidylinositol (PI) hydrolysis and PKC activity in RAW cells; both were inhibited by genestein. The PKC inhibitors (staurosporine, calphostin C, Ro 31-8220, or Go 6976) or long-term 12-O-tetradecanoylphorbol 13-acetate (TPA) treatment also resulted in inhibition of LPS-induced NO release and iNOS expression. Western blot analysis showed expression of PKC-alpha, -betaI, -delta, -eta, and -zeta in RAW cells; down-regulation of PKC-alpha, -betaI, and -delta, but not -eta, was seen after long-term TPA treatment, indicating the possible involvement of one or all of PKC-alpha, -betaI, and -delta, but not -eta, in LPS-mediated effects. Treatment with antisense oligonucleotides for these isoforms further demonstrated the involvement of PKC-alpha, -betaI, and delta, but not -eta, in LPS responses. Stimulation of cells with LPS for 1 h caused activation of NF-kappaB in the nuclei by detection of NF-kappaB-specific DNA-protein binding; this was inhibited by genestein, U73122, D609, calphostin C, or antisense oligonucleotides for PKC-alpha, -betaI, and -delta, but not -eta. These data suggest that LPS activates PI-PLC and PC-PLC via an upstream tyrosine kinase to induce PKC activation, resulting in the stimulation of NF-kappaB DNA-protein binding, then initiated the expression of iNOS and NO release. PKC isoforms alpha, betaI, and delta were shown to be involved in the regulation of these LPS-induced events.
机译:在RAW 264.7巨噬细胞中研究了蛋白激酶C(PKC)活化的信号传导途径以及PKC亚型在LPS诱导的一氧化氮(NO)释放中的作用。酪氨酸激酶抑制剂Genestein减弱了LPS诱导的NO释放和诱导型一氧化氮合酶(iNOS)的表达,磷脂酰肌醇特异性磷脂酶C(PI-PLC)抑制剂U73122和磷脂酰胆碱特异性磷脂酶C(PC-PLC)抑制剂也是如此。 LPS刺激RAW细胞中的磷脂酰肌醇(PI)水解和PKC活性;两者都被染料木黄酮抑制。 PKC抑制剂(星形孢菌素,钙磷蛋白C,Ro 31-8220或Go 6976)或长期使用12-O-十四烷酰佛波醇13-乙酸盐(TPA)处理也可抑制LPS诱导的NO释放和iNOS表达。 Western印迹分析显示RA​​W细胞中PKC-alpha,-betaI,-delta,-eta和-zeta的表达;长期TPA治疗后,发现PKC-α,-βI和-δ而不是-eta的下调,表明可能参与了PKC-α,-βI和-δ的一个或全部,但是在脂多糖介导的效应中不是-eta。用这些同工型的反义寡核苷酸处理进一步证明,PKC-α,-βI和δ(而非β)参与了LPS反应。用LPS刺激细胞1小时,通过检测NF-kappaB特异的DNA-蛋白质结合来激活核中NF-kappaB。它被genestein,U73122,D609,calphostin C或PKC-alpha,-betaI和-delta(而非-eta)的反义寡核苷酸抑制。这些数据表明,LPS通过上游酪氨酸激酶激活PI-PLC和PC-PLC,以诱导PKC激活,从而刺激NF-κBDNA-蛋白结合,然后启动iNOS的表达和NO释放。 PKC亚型的alpha,betaI和delta被证明参与这些LPS诱导事件的调节。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号